Keyron Appoints New Chief Executive Officer

LONDON, Feb. 7 (Korea Bizwire) — Today Keyron, the medical technology group focused on reversing type 2 diabetes, non-alcoholic steatohepatitis (NASH), and obesity via an innovative medical device platform, announced the appointment of Carl D Francis as Chief Executive Officer. “The continuing rise in obesity, diabetes, and all forms of fatty liver disease is one of the [...]